DENTSPLY SIRONA Inc
NASDAQ:XRAY
Intrinsic Value
Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. [ Read More ]
The intrinsic value of one
XRAY
stock under the Base Case scenario is
48.78
USD.
Compared to the current market price of 34.16 USD,
DENTSPLY SIRONA Inc
is
Undervalued by 30%.
Whether you're assessing long-term stability or short-term opportunities, Historical Valuation serves as a vital tool to enhance your investment approach, enabling you to make more informed investment decisions.
Sign up
to access DENTSPLY SIRONA Inc's intrinsic value history.
No restrictions, no limits.
All stocks, all tools.
Look for stocks that have been historically overvalued but are now trading below their intrinsic value.
Avoid stocks that are always undervalued and never reach their intrinsic value.
Find stocks that have historically corrected quickly from being undervalued to reaching their intrinsic value.
There are two methods to calculate the Intrinsic Value of a stock: DCF Valuation and Relative Valuation. We take the average of these two methods to estimate the intrinsic value as accurately as possible. You can see the Intrinsic Value of a stock at the top of this page.
DCF Value
Discounted Cash Flow
Fundamental Analysis
Balance Sheet Decomposition
DENTSPLY SIRONA Inc
| Current Assets | 1.9B |
| Cash & Short-Term Investments | 295m |
| Receivables | 670m |
| Other Current Assets | 955m |
| Non-Current Assets | 5.7B |
| PP&E | 963m |
| Intangibles | 4.5B |
| Other Non-Current Assets | 256m |
| Current Liabilities | 1.3B |
| Accounts Payable | 265m |
| Accrued Liabilities | 617m |
| Other Current Liabilities | 389m |
| Non-Current Liabilities | 2.7B |
| Long-Term Debt | 1.8B |
| Other Non-Current Liabilities | 832m |
XRAY Profitability Score
Profitability Due Diligence
DENTSPLY SIRONA Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
Score
DENTSPLY SIRONA Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
XRAY Solvency Score
Solvency Due Diligence
DENTSPLY SIRONA Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.
Score
DENTSPLY SIRONA Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
XRAY Price Targets Summary
DENTSPLY SIRONA Inc
According to Wall Street analysts, the average 1-year price target for
XRAY
is 45.9 USD
with a low forecast of 41.41 USD and a high forecast of 53.55 USD.
Ownership
XRAY Insider Trading
Buy and sell transactions by insiders
| Period | Sold | Bought | Net |
|---|---|---|---|
| 3 Months |
|
|
|
| 6 Months |
|
|
|
| 9 Months |
|
|
|
| 12 Months |
|
|
|
Shareholder Return
XRAY Price
DENTSPLY SIRONA Inc
| Average Annual Return | 13.5% |
| Standard Deviation of Annual Returns | 25.61% |
| Max Drawdown | -61% |
| Market Capitalization | 7.2B USD |
| Shares Outstanding | 214 500 000 |
| Percentage of Shares Shorted | 3.52% |
Company Profile
DENTSPLY SIRONA Inc
Country
Industry
Market Cap
Dividend Yield
Description
Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. The company is headquartered in York, Pennsylvania and currently employs 15,000 full-time employees. The firm develops, manufactures and markets solutions, including dental equipment and dental consumable products. The Company’s segments include Technologies & Equipment (T&E) and Consumables. The T&E segment is engaged in designing, manufacturing, sales and distribution of its Dental Technology and Equipment Products and Healthcare Consumable Products. Its products include dental implants, computer-aided design/computer-aided manufacturing systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as consumable medical device products. The Consumables segment is engaged in designing, manufacturing, sales and distribution of the Company's Dental Consumable Products, which include preventive, restorative, endodontic and dental laboratory products. The company also offers treatment planning and a clear aligner solution delivered directly to a consumer's home.
Contact
IPO
Employees
Officers
The intrinsic value of one
XRAY
stock under the Base Case scenario is
48.78
USD.
Compared to the current market price of 34.16 USD,
DENTSPLY SIRONA Inc
is
Undervalued by 30%.
Sensibly Priced Quality
Significantly Undervalued
Magic Formula
High Growth
